Tabula Rasa HealthCare, Inc.
TRHC · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $90 | $88 | $83 | $77 |
| % Growth | 2% | 6.7% | 7.3% | – |
| Cost of Goods Sold | $68 | $68 | $63 | $60 |
| Gross Profit | $23 | $21 | $20 | $17 |
| % Margin | 25% | 23.5% | 23.8% | 21.9% |
| R&D Expenses | $2 | $1 | $3 | $4 |
| G&A Expenses | $18 | $17 | $16 | $28 |
| SG&A Expenses | $20 | $19 | $19 | $31 |
| Sales & Mktg Exp. | $3 | $2 | $3 | $3 |
| Other Operating Expenses | $1 | $6 | $6 | $6 |
| Operating Expenses | $28 | $27 | $28 | $41 |
| Operating Income | -$9 | -$5 | -$9 | -$24 |
| % Margin | -10% | -6% | -10.6% | -30.7% |
| Other Income/Exp. Net | -$4 | -$1 | -$10 | -$2 |
| Pre-Tax Income | -$10 | -$7 | -$18 | -$26 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$10 | -$7 | -$18 | -$26 |
| % Margin | -10.9% | -8% | -22.2% | -33.6% |
| EPS | -0.39 | -0.28 | -0.74 | -1.06 |
| % Growth | -39.3% | 62.2% | 30.2% | – |
| EPS Diluted | -0.39 | -0.28 | -0.74 | -1.06 |
| Weighted Avg Shares Out | 25 | 25 | 25 | 24 |
| Weighted Avg Shares Out Dil | 25 | 25 | 25 | 24 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $2 | $3 |
| Depreciation & Amortization | $6 | $6 | $7 | $6 |
| EBITDA | -$3 | $1 | -$10 | -$17 |
| % Margin | -3.7% | 1% | -11.8% | -22% |